메뉴 건너뛰기




Volumn 21, Issue 24, 2000, Pages 1990-1992

How hot is inflammation in acute coronary syndrome?

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; ANTITHROMBOCYTIC AGENT; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; SIBRAFIBAN;

EID: 0034538007     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.2000.2472     Document Type: Editorial
Times cited : (3)

References (12)
  • 1
    • 0028120906 scopus 로고
    • Collaborative overview of randomised trials of antiplatelet therapy I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
    • (1994) Br Med J , vol.308 , pp. 81-106
  • 6
    • 0034728088 scopus 로고    scopus 로고
    • Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes: A randomised trial
    • (2000) Lancet , vol.355 , pp. 337-345
  • 7
    • 0032212143 scopus 로고    scopus 로고
    • Induction of fibrinogen binding and platelet aggregation as a potential intrinsic property of various glycoprotein IIb/IIIa inhibitors
    • (1998) Blood , vol.92 , pp. 3240-3249
    • Peter, K.1    Schaars, M.2    Lanen, J.3
  • 10
    • 0034537968 scopus 로고    scopus 로고
    • A randomized placebo-controlled trial to assess the efficacy of anti-inflammatory therapy with methylprednisolone in unstable angina (MUNA trial)
    • (2000) Eur Heart J , vol.21 , pp. 2026-2032
    • Azar, R.R.1    Rinfret, S.2    Theroux, P.3
  • 11
    • 0023805341 scopus 로고
    • Randomised trial of intravenous streptokinase, aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction: ISIS-2
    • (1988) Lancet , vol.2 , pp. 349-360


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.